DocGo (DCGO) Misses Q3 EPS by 1c; Offers FY23 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
DocGo Announces Record Third Quarter 2023 Results
November 6, 2023 4:05 PM ESTCompany Raises 2023 Revenue Guidance to $615-$625 Million, up From a Previous Range of $540-$550 Million And
Increases Adjusted EBITDA1 Guidance to $50-$55 Million, up From a Previous Range of $48-$53 Million
Management to Host Conference Call and Webcast Today at 5:00 p.m. EDT
NEW YORK--(BUSINESS WIRE)-- DocGo Inc. (Nasdaq: DCGO) (DocGo or the Company), a leading provider of technology-enabled mobile health services, today announced financial and operating results for the quarter ended September 30, 2023.
Q3 2023 Financial... More
